Sara Anvari, MD, MSc

Personal Statement

As the Director of Clinical Trials for the TCH Food Allergy Program, Dr. Anvari has been an advocate for food allergic patients and has helped develop and bring the latest food allergy clinical trials to Texas Children's Hospital. 

In addition to her strong interest in preventing and treating all forms of allergic and immunological conditions, Dr. Anvari has established subspecialty clinics focused on treating patients with food protein-induced enterocolitis syndrome (FPIES), COVID vaccine allergies and penicillin allergy delableing. She is committed to improving the quality of life for infants, children and adolescents with allergic and immunologic disorders. 

Dr. Anvari currently leads clinical and basic science research projects evaluating food, drug, and vaccine allergies. She has dedicated her career, thus far, to understand and investigate the underlying immune mechanisms driving these conditions. Dr. Anvari is dedicated to providing her patients and their families with excellent and comprehensive medical care.

View News Articles:

1 in 5 adults think they have a food allergy. Fewer actually do, study shows 

Sara Anvari, MD, MSc: Urticaria and Angioedema Events Following COVID-19 Vaccination

61% of anaphylactic events occur in the home

Urticaria, angioedema events account for 13% of COVID-19 vaccine reactions

Clinical Interests

Drug Allergy, Food Allergy (IgE and non-IgE mediated food allergies)

Education

,

,

,

,

Organizations

,

,

,

,

* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.

Research interests

Food Protein-Induced Enterocolitis Syndrome and Penicillin and Other Drug/Vaccine Allergies

Anvari S and Ruffner MA. Adult Food-Protein Induced Enterocolitis Syndrome. Front Allergy. 2022; 3:889879. eCollection 2022. PMID: 35769585

Anvari S, Brunner S, Tuano KS, Su B, Karnaneedi S, Lopata A, Davis CM. Similar IgE Binding Patters in Gulf of Mexico and Southeast Asian Shrimp Species in US Shrimp Allergic Patients. Allergy. 2022 May 7. Online ahead of print. PMID: 35524542

Anvari S, Watkin LB, Minard CG, Schuster K, Hassan O, Anagnostou A, Orange JS, Corry DB, Davis CM. Reduced pro-inflammatory dendritic cell phenotypes are a potential indicator of successful peanut oral immunotherapy. PLOS One. 2022; 17(5):30264674. PMID: 35617270

Fernandez-Davila N, Taylor M, Anvari S. Hypersensitivity Reactions to COVID-19 Vaccines: Identify High-Risk Children and Vaccinate the Rest. JAMA Pediatr. 2022 Mar. Online ahead of print. PMID: 35254412 

Blumenthal KG, Freeman EE, Saff RR, Robinson LB, Wolfson AR, Foreman RK, Hashimoto D, Banerji A, Li L, Anvari S, Shenoy ES. Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2. N Engl J Med. 2021 Apr; 384(13):1273-1277. PMID 33657292

View PubMed Publications